Baxter Expands US Pharma Portfolio
Baxter has expanded its US pharmaceuticals portfolio by launching five injectable drugs, including Vancomycin to treat infections of methicillin-resistant staphylococci.
Baxter has expanded its US pharmaceuticals portfolio by launching five injectable drugs, including Vancomycin to treat infections of methicillin-resistant staphylococci.
A closer look at suction and secretion clearance devices from Monaghan Medical, Seoil Pacific, and International Biophysics Corp.
As healthcare costs and hospital readmissions continue to rise, the field of respiratory care has begun to embrace the advantages of home care solutions for chronic lung patients.